Literature DB >> 6808683

Role of the components of the gastroduodenal contents in experimental acid esophagitis.

K D Lillemoe, L F Johnson, J W Harmon.   

Abstract

Esophagitis has been associated with the reflux of acidic gastroduodenal contents. These contents may contain not only HCl but also pepsin, bile, and pancreatic enzymes. This experiment was designed to compare the roles of these components in experimental acid esophagitis. The esophagus of the rabbit was cannulated and perfused continuously via a recirculating system with pH 2 acid test solution. Net flux of H+, K+, glucose, and hemoglobin plus the recovery of tritiated water were determined before and after the addition of pepsin, taurodeoxycholate, or trypsin. Afterward the esophageal segments were graded for gross and microscopic esophagitis. These studies show that pepsin caused significant gross and microscopic esophagitis. Moreover, pepsin also caused significant increases in H+, K+, glucose, and hemoglobin flux as well as decreased recovery of tritiated water. Taurodeoxycholate increased esophageal mucosal permeability to H+, K+, and glucose and decreased the recovery of tritiated water but did not cause significant pathologic change. Trypsin and acid alone did not result in significant esophagitis by either pathologic or ionic permeability criteria. These results show tha disruption of the esophageal mucosal barrier cannot be equated with pathologic injury and that different components of the gastroduodenal contents may have different sites or mechanisms of injury.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808683

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  31 in total

1.  What is the best reconstruction method after distal gastrectomy for gastric cancer?

Authors:  Moon-Soo Lee; Sang-Hoon Ahn; Ju-Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang; Nayoung Kim; Won Woo Lee
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

2.  Reproducibility of 24 hour oesophageal pH studies in infants.

Authors:  F J Hampton; U M MacFadyen; H Simpson
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 3.  How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.

Authors:  Philippe G Guillem
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits.

Authors:  H P Tay; R C Chaparala; J W Harmon; J Huesken; N Saini; F Z Hakki; E J Schweitzer
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

5.  Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux.

Authors:  S Mattioli; V Pilotti; M Spangaro; W F Grigioni; R Zannoli; V Felice; A Conci; G Gozzetti
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

6.  Oesophageal clearance of acid and bile: a combined radionuclide, pH, and Bilitec study.

Authors:  G H Koek; R Vos; P Flamen; D Sifrim; F Lammert; B Vanbilloen; J Janssens; J Tack
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Duodenogastric reflux in patients with Barrett's esophagus.

Authors:  J P Waring; J Legrand; A Chinichian; R A Sanowski
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

Review 8.  Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Authors:  Joerg Theisen; Jeffrey H Peters; Hubert J Stein
Journal:  World J Surg       Date:  2003-07-17       Impact factor: 3.352

Review 9.  Alkaline reflux oesophagitis.

Authors:  D L Stoker; J G Williams
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  pH-metric analysis after successful antireflux surgery: comparison of 24-hour pH profiles in patients undergoing floppy fundoplication or Roux-en-Y duodenal diversion.

Authors:  J T Salminen; J A Salo; J A Tuominen; O J Rämö; M Färkkilä; S P Mattila
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.